← Open Payments lookup

MELISSA LACAYO: Open Payments

NPI 1639799265 · BELL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$964 in 43 payments from 18 companies in 2025. Trend: 2023 $965 · 2024 $1,423 · 2025 $964

Food & beverage: $964
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.6$142
Lilly USA, LLC5$122
GlaxoSmithKline, LLC.4$92
Novo Nordisk Inc4$87
Dexcom, Inc.3$85
Sumitomo Pharma America, Inc.3$83
AstraZeneca Pharmaceuticals LP3$55
Lundbeck LLC3$55
SANOFI-AVENTIS U.S. LLC1$40
Amgen Inc.2$37

Products named: JARDIANCE, MOUNJARO, Dexcom G6 Transmitter, GEMTESA, REXULTI, TRELEGY ELLIPTA, TZIELD, KRYSTEXXA.

Industry payments across CA — which companies pay providers there.